Medical Cannabis
- Generic Name
- Medical Cannabis
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- FTS5RM302N
- Background
The use of the plant species Cannabis sativa and Cannabis indica, popularly known as marijuana, has gained popularity in recent years for the management of a wide variety of medical conditions as a wave of legalization in North America has changed public and medical opinion on its use. Consequently, an expanding body of evidence has begun to emerge that has ...
- Associated Conditions
- -
- Associated Therapies
- -
A Randomized Trial of Medical Cannabis in Patients With Advanced Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 32
- Registration Number
- NCT06605430
- Locations
- 🇺🇸
HealthPartners Cancer Research Center, Saint Louis Park, Minnesota, United States
A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 20
- Registration Number
- NCT06518434
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
- Conditions
- Interventions
- First Posted Date
- 2024-07-08
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Syqe Medical
- Target Recruit Count
- 192
- Registration Number
- NCT06490445
- Locations
- 🇲🇩
Clinical Republican Hospital \"Timofei Mosneaga\", ARENSIA E.M., Chisinau, Moldova, Republic of
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
- Conditions
- Interventions
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 40
- Registration Number
- NCT06351540
- Locations
- 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
- Conditions
- Interventions
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 90
- Registration Number
- NCT06293040
- Locations
- 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.
- Conditions
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- M. H MediCane Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06217146
- Locations
- 🇮🇱
Laniado Hospital, Netanya, Israel
🇮🇱Sheba Medical Center, Ramat-Gan, Israel
🇮🇱Tel-Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel
Effects of Marijuana on Neuropathic Pain and Spasticity in Spinal Cord Injury Patients
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Khon Kaen University
- Target Recruit Count
- 20
- Registration Number
- NCT06190470
- Locations
- 🇹🇭
Faculty of Medicine Khon Kaen University, Khon Kaen, Thailand
Cannabis for Obesity Trial
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 40
- Registration Number
- NCT06137365
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
- Conditions
- Interventions
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 48
- Registration Number
- NCT05999383
- Locations
- 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States
Age-dependent Effects of Smoked and Oral Delta-9-THC
- Conditions
- Interventions
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 103
- Registration Number
- NCT05865470
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.